David Cameron

David Cameron

UNVERIFIED PROFILE

Are you David Cameron?   Register this Author

Register author
David Cameron

David Cameron

Publications by authors named "David Cameron"

Are you David Cameron?   Register this Author

100Publications

2350Reads

36Profile Views

On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer.

Breast Cancer Res 2019 Jun 14;21(1):73. Epub 2019 Jun 14.

University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-019-1159-3DOI Listing
June 2019

Combining clustering and classification ensembles: A novel pipeline to identify breast cancer profiles.

Artif Intell Med 2019 Jun 15;97:27-37. Epub 2019 May 15.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.artmed.2019.05.002DOI Listing
June 2019

Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.

Antimicrob Agents Chemother 2019 Mar 26;63(3). Epub 2019 Feb 26.

Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia

View Article

Download full-text PDF

Source
http://aac.asm.org/lookup/doi/10.1128/AAC.01926-18
Publisher Site
http://dx.doi.org/10.1128/AAC.01926-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395924PMC
March 2019

Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES.

J Control Release 2019 Mar 4;298:1-11. Epub 2019 Feb 4.

School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2019.02.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414755PMC
March 2019

Antibiotic resistance and host immune evasion in mediated by a metabolic adaptation.

Proc Natl Acad Sci U S A 2019 02 11;116(9):3722-3727. Epub 2019 Feb 11.

Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, VIC 3800, Australia;

View Article

Download full-text PDF

Source
http://www.pnas.org/lookup/doi/10.1073/pnas.1812066116
Publisher Site
http://dx.doi.org/10.1073/pnas.1812066116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397524PMC
February 2019

Concerns about cardiotoxicity in the HERA trial - Authors' reply.

Lancet 2018 12;390(10114):2767-2768

Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(17)31940-2DOI Listing
December 2018

On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review.

Glob Health Action 2018 ;11(1):1447828

a Department of Public Health and Clinical Medicine , Umeå University , Umeå , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/16549716.2018.1447828DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930346PMC
October 2018

Pharmacists' Role in Opioid Safety: A Focus Group Investigation.

Pain Med 2018 09;19(9):1799-1806

Oregon Health and Science University, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/pm/pnx139DOI Listing
September 2018

A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.

J Bacteriol 2018 Sep 10;200(17). Epub 2018 Aug 10.

Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JB.00303-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088157PMC
September 2018

Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial.

Breast Cancer Res Treat 2018 Jun 12;169(3):497-505. Epub 2018 Feb 12.

Department of Medical Oncology, Institut Bergonié Unicancer, Université de Bordeaux, INSERM U1218, INSERM CIC1401, 229 Cours de l'Argonne, 33000, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4698-xDOI Listing
June 2018

Clinical mentoring to improve quality of care provided at three NIM-ART facilities: A mixed methods study.

Afr J Prim Health Care Fam Med 2018 Jun 14;10(1):e1-e7. Epub 2018 Jun 14.

School of Health Systems and Public Health, University of Pretoria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018522PMC
http://dx.doi.org/10.4102/phcfm.v10i1.1579DOI Listing
June 2018

Reporting From the Front Lines: Implementing Oregon's Alternative Payment Methodology in Federally Qualified Health Centers.

J Ambul Care Manage 2017 Oct/Dec;40(4):339-346

Oregon Health & Science University (Drs Cottrell, DeVoe, and Cohen, Mss Hall, Angier, Likumahuwa-Ackman, and Keller, and Messrs Kautz and Cameron), OCHIN, Inc (Drs Cottrell and DeVoe), and Oregon Primary Care Association (Ms Sisulak), Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JAC.0000000000000198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837032PMC
May 2018

Predictive performance and inter-laboratory reproducibility in assessing eye irritation potential of water- and oil-soluble mixtures using the Short Time Exposure test method.

Toxicol In Vitro 2018 Apr 4;48:78-85. Epub 2018 Jan 4.

Faculty of Engineering, Department of Materials Science and Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya-ku, Yokohama, Kanagawa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tiv.2017.12.018DOI Listing
April 2018

Positive affect and physical activity: Testing effects on goal setting, activation, prioritisation, and attainment.

Psychol Health 2018 02 23;33(2):258-274. Epub 2017 Apr 23.

c Department of Psychology and Neuroscience , University of North Carolina at Chapel Hill , Chapel Hill , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/08870446.2017.1
Publisher Site
http://dx.doi.org/10.1080/08870446.2017.1314477DOI Listing
February 2018

Overall survival in MERiDiAN, a double-blind placebo-controlled randomised phase III trial evaluating first-line bevacizumab plus paclitaxel for HER2-negative metastatic breast cancer.

Eur J Cancer 2018 02 23;90:153-155. Epub 2017 Nov 23.

Baylor Charles A. Sammons Cancer Center, US Oncology and Texas Oncology, 3410 Worth Street, Suite 400, Dallas, TX, 75246, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.10.018DOI Listing
February 2018

Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy.

J Natl Cancer Inst 2018 01;110(1)

European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France; The Christie NHS Foundation Trust, Manchester, UK; University of Pittsburgh Cancer Institute and School of Medicine, Pittsburgh, PA; Mayo Clinic Rochester, Rochester, MN; University of Tubingen, Tubingen, Germany; University of Edinburgh, Western General Hospital, Edinburgh, UK; Bristol-Myers Squibb, Wallingford, CT; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK; Universitas Brawijaya, Malang, Indonesia; IDDI, Louvain-la-Neuve, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx133DOI Listing
January 2018

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial.

Lancet Oncol 2017 11 13;18(11):1543-1552. Epub 2017 Oct 13.

IMIM-CIBERONC, Barcelona; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30603-4DOI Listing
November 2017

Atomic layer deposition-A novel method for the ultrathin coating of minitablets.

Int J Pharm 2017 Oct 9;531(1):47-58. Epub 2017 Aug 9.

Industrial Pharmacy, Faculty of Pharmacy, University of Helsinki, P.O. Box 56 (Viikinkaari 5E, Biocenter 2), FI-00014, Finland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03785173173069
Publisher Site
http://dx.doi.org/10.1016/j.ijpharm.2017.08.010DOI Listing
October 2017

Integrating behavioral health under an ACO global budget: barriers and progress in Oregon.

Am J Manag Care 2017 Sep 1;23(9):e303-e309. Epub 2017 Sep 1.

Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239. E-mail:

View Article

Download full-text PDF

Source
September 2017

Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study.

Eur J Cancer 2017 07 18;79:226-234. Epub 2017 May 18.

Department of Medical Oncology, Institut Bergonié Unicancer, Univ. Bordeaux, INSERM U1218, INSERM CIC1401 Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.04.012DOI Listing
July 2017

Surface modification of acetaminophen particles by atomic layer deposition.

Int J Pharm 2017 Jun 18;525(1):160-174. Epub 2017 Apr 18.

Laboratory of Inorganic Chemistry, University of Helsinki, P.O. Box 55 (A.I.Virtasen aukio 1), FI-00014 Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2017.04.031DOI Listing
June 2017

The immediate cardiovascular response to joint mobilization of the neck - A randomized, placebo-controlled trial in pain-free adults.

Musculoskelet Sci Pract 2017 04 4;28:71-78. Epub 2017 Feb 4.

Doctor of Physical Therapy Program, Sacred Heart University, Fairfield, CT, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msksp.2017.01.013DOI Listing
April 2017

Usefulness of Echocardiography/Doppler to Reliably Predict Elevated Left Ventricular End-Diastolic Pressure in Patients With Pulmonary Hypertension.

Am J Cardiol 2017 03 2;119(5):790-794. Epub 2016 Dec 2.

Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2016.11.016DOI Listing
March 2017

The impact of positive affect on health cognitions and behaviours: a meta-analysis of the experimental evidence.

Health Psychol Rev 2015 11;9(3):345-65. Epub 2014 Jun 11.

a Department of Psychology , University of Sheffield , Sheffield S10 2TP , UK.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17437199.2014.9
Publisher Site
http://dx.doi.org/10.1080/17437199.2014.923164DOI Listing
December 2016

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

N Engl J Med 2016 11 7;375(18):1738-1748. Epub 2016 Oct 7.

From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609709DOI Listing
November 2016

What palliative care-related problems do patients with drug-resistant or drug-susceptible tuberculosis experience on admission to hospital? A cross-sectional self-report study.

Palliat Med 2016 10 28;30(9):862-8. Epub 2016 Jul 28.

Department of Family Medicine, University of Pretoria, Pretoria, South Africa Foundation for Professional Development, Pretoria, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269216316637240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021214PMC
October 2016

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.

J Natl Cancer Inst 2016 09 29;108(9). Epub 2016 Apr 29.

Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB); University of Toronto, Toronto, Canada (JMSB); University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC); Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC); University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP); University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME); Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR); University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC); University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF); University of Alberta, Edmonton, AB, Canada (CM); Kings College London, Guy's Hospital, London, UK (SEP); Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD); Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM); National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939629PMC
September 2016

England's 30-day chemotherapy mortality: a measure of quality of care?

Authors:
David Cameron

Lancet Oncol 2016 09 30;17(9):1172-3. Epub 2016 Aug 30.

Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30405-3DOI Listing
September 2016

Sisyphean Efforts: Establishing the Correct Risk-Benefit Balance for Adjuvant Therapies.

J Clin Oncol 2016 Mar 19;34(9):895-7. Epub 2016 Jan 19.

University of Edinburgh Cancer Research Centre, Edinburgh, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.2255DOI Listing
March 2016

Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer.

J Clin Oncol 2016 Mar 25;34(9):936-44. Epub 2016 Jan 25.

Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/21/JCO.2015.62
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.62.4767
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4767DOI Listing
March 2016

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience.

Breast Cancer Res Treat 2016 Jan 26;155(1):127-32. Epub 2015 Dec 26.

Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs10549-015-36
Web Search
http://link.springer.com/10.1007/s10549-015-3656-0
Publisher Site
http://dx.doi.org/10.1007/s10549-015-3656-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947530PMC
January 2016

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.

J Pathol Clin Res 2016 Jan 15;2(1):32-40. Epub 2016 Jan 15.

Division of Cancer and Stem CellsBreast Cancer Pathology Research Group, School of Medicine, University of Nottingham, Nottingham City HospitalHucknall RoadNottinghamNG5 1PB; Cellular Pathology, Nottingham University Hospitals NHS TrustHucknall RoadNottinghamNG5 1PB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858129PMC
January 2016

Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms.

Sci Rep 2015 Dec 21;5:18578. Epub 2015 Dec 21.

Department of Microbiology, School of Medicine, Nursing and Health Sciences, Monash University, Clayton 3800, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep18578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685274PMC
December 2015

Removing the primary tumour in metastatic breast cancer.

Authors:
David Cameron

Lancet Oncol 2015 Oct 9;16(13):1284-5. Epub 2015 Sep 9.

University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00221-1DOI Listing
October 2015

Insights on virulence from the complete genome of Staphylococcus capitis.

Front Microbiol 2015 23;6:980. Epub 2015 Sep 23.

Department of Microbiology, Monash University Melbourne, VIC, Australia ; Department of Infectious Diseases, Alfred Hospital Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmicb.2015.00980DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585213PMC
October 2015

Attachment of Poly(l-lactide) Nanoparticles to Plasma-Treated Non-Woven Polymer Fabrics Using Inkjet Printing.

Macromol Biosci 2015 Sep 27;15(9):1274-82. Epub 2015 May 27.

ASTRaL team, Laboratory of Green Chemistry, Lappeenranta University of Technology, Sammonkatu 12, 50130 Mikkeli, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mabi.201500067
Publisher Site
http://dx.doi.org/10.1002/mabi.201500067DOI Listing
September 2015

The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides.

Antimicrob Agents Chemother 2015 Jul 6;59(7):3761-70. Epub 2015 Apr 6.

International Partnership for Microbicides, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.04954-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468677PMC
July 2015

Species differences in tumour responses to cancer chemotherapy.

Philos Trans R Soc Lond B Biol Sci 2015 Jul;370(1673)

Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Easter Bush EH25 9RG, UK

View Article

Download full-text PDF

Source
http://rstb.royalsocietypublishing.org/lookup/doi/10.1098/rs
Publisher Site
http://dx.doi.org/10.1098/rstb.2014.0233DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581034PMC
July 2015

Factors associated with retention in HIV care at Sediba Hope Medical Centre.

South Afr J HIV Med 2015 1;16(1):347. Epub 2015 Jul 1.

Foundation for Professional Development, Pretoria, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4102/sajhivmed.v16i1.347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843141PMC
July 2015

Reelin Prevents Apical Neurite Retraction during Terminal Translocation and Dendrite Initiation.

J Neurosci 2015 Jul;35(30):10659-74

Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York 13210, and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1523/JNEUROSCI.1629-15.2015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518046PMC
July 2015

Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.

J Clin Oncol 2015 May 20;33(15):1680-7. Epub 2015 Apr 20.

John M.S. Bartlett, Ontario Institute for Cancer Research; Frances P. O'Malley, St Michael's Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto; John M.S. Bartlett, Frances P. O'Malley, and Lois E. Shepherd, National Cancer Institute of Canada Clinical Trials Group; Lois E. Shepherd, Queen's University, Kingston, Canada; John M.S. Bartlett, Alison F. Munro, and David A. Cameron, University of Edinburgh, Edinburgh; Christopher C. McConkey, Janet A. Dunn, and Christopher J. Poole, University of Warwick, Coventry; Helena M. Earl and Carlos Caldas, University of Cambridge, Cambridge; Christopher J. Twelves, St James's University Hospital, Leeds; Daniel W. Rea, University of Birmingham, Birmingham, United Kingdom; Christine Desmedt and Denis P. Larsimont, Université Libre de Bruxelles, Brussels, Belgium; Fatima Cardoso, Champalimaud Cancer Centre, Lisbon, Portugal; Maj-Britt Jensen and Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; and Angelo Di Leo, Hospital of Prato, Prato, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.7869DOI Listing
May 2015

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Lancet Oncol 2015 Mar 28;16(3):266-73. Epub 2015 Jan 28.

Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)71221-5DOI Listing
March 2015

Pathological complete response in breast cancer--authors' reply.

Lancet 2015 Jan;385(9963):114-5

German Breast Group, Neu-Isenburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)60018-6DOI Listing
January 2015

Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.

J Natl Cancer Inst 2014 Dec 7;106(12). Epub 2014 Nov 7.

Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357796PMC
December 2014

A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.

Eur J Cancer 2014 Sep 11;50(14):2367-74. Epub 2014 Jul 11.

MRC Centre for Reproductive Health, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049140075
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2014.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166459PMC
September 2014

Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01).

J Clin Oncol 2014 Jul 9;32(20):2159-65. Epub 2014 Jun 9.

Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet; Evandro de Azambuja, Breast European Adjuvant Study Team; Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium; Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie; David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh; Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research; Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom; Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands; Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA; Jutta Steinseifer, F. Hoffmann-La Roche, Basel; Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland; Michael Untch, HELIOS Klinikum Berlin, Buch; Christian Jackisch, Klinikum Offenbach, Offenbach, Germany; Luca Gianni, San Raffaele Institute, Milan, Italy; Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia; and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.9288DOI Listing
July 2014

Breast cancer chemoprevention: little progress in practice?

Authors:
David A Cameron

Lancet 2014 Mar 12;383(9922):1018-20. Epub 2013 Dec 12.

Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)62555-6DOI Listing
March 2014

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.

Eur J Cancer 2013 Nov 19;49(16):3404-11. Epub 2013 Aug 19.

MRC Centre for Reproductive Health, University of Edinburgh, Queens Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.07.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807650PMC
November 2013

Pertuzumab for the treatment of metastatic breast cancer.

Expert Rev Anticancer Ther 2013 Aug;13(8):907-18

Division of Pathology, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XU, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2013.814419DOI Listing
August 2013